QingSong Health Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Net Income	-379.72	10.4	73.65	-2.06
Depreciation & Amortization	4.38	4.93	4.62	5.74
Other Amortization	0.05	0.05	0.05	0.03
Loss (Gain) From Sale of Assets	-	-0.27	0	0.12
Loss (Gain) From Sale of Investments	403.52	50.26	44.8	145.63
Stock-Based Compensation	12.28	12.95	1.17	7.67
Provision & Write-off of Bad Debts	0.24	0.04	0.29	0.2
Other Operating Activities	-1.78	-1.71	7.81	20.81
Change in Accounts Receivable	26.59	27.09	-67.62	-28.32
Change in Accounts Payable	-15.88	-8.29	35.53	-36.2
Change in Unearned Revenue	9.72	-15.73	-42.23	-83.09
Change in Other Net Operating Assets	22.68	4.07	-50.28	26.67
Operating Cash Flow	82.09	83.79	7.83	57.2
Operating Cash Flow Growth	-2.03%	969.58%	-86.30%	-
Capital Expenditures	-0.72	-1.01	-0.18	-
Sale of Property, Plant & Equipment	0.01	-	-	0.14
Cash Acquisitions	-	-2.22	-	-
Investment in Securities	-21.54	28.69	-108.19	-
Other Investing Activities	-	-8.93	103.48	-95.03
Investing Cash Flow	-22.25	16.53	-4.89	-94.9
Short-Term Debt Repaid	-	-26.08	-	-
Long-Term Debt Repaid	-4.25	-4.54	-4.95	-4.99
Total Debt Repaid	-4.25	-30.62	-4.95	-4.99
Net Debt Issued (Repaid)	-4.25	-30.62	-4.95	-4.99
Issuance of Common Stock	518.01	-	-	-
Financing Cash Flow	439.41	-30.62	-4.95	-4.99
Foreign Exchange Rate Adjustments	0.07	-0.34	-0.39	0.64
Net Cash Flow	499.32	69.36	-2.39	-42.04
Free Cash Flow	81.37	82.79	7.65	57.2
Free Cash Flow Growth	-1.71%	981.75%	-86.62%	-
Free Cash Flow Margin	6.48%	8.76%	1.56%	14.53%
Free Cash Flow Per Share	0.98	0.82	0.04	0.71
Cash Income Tax Paid	-	-	0.26	7.34
Levered Free Cash Flow	111.69	53.8	71.32	-
Unlevered Free Cash Flow	111.69	53.8	71.32	-
Change in Working Capital	43.11	7.14	-124.59	-120.94

Source: S&P Capital IQ. Standard template. Financial Sources.